Jerry Tan1, Hong Liu2, James J Leyden3, Matthew J Leoni4. 1. University of Western Ontario, Schulich School of Medicine and Dentistry (Windsor campus), Windsor, Ontario, Canada; Private practice, Windsor, Ontario, Canada. 2. Galderma Research and Development, Princeton, New Jersey. 3. University of Pennsylvania, Philadelphia, Pennsylvania. 4. Galderma Research and Development, Princeton, New Jersey. Electronic address: matthew.leoni@galderma.com.
Abstract
BACKGROUND: Facial erythema is a clinical hallmark of rosacea and often causes social and psychological distress. Although facial erythema assessments are a common endpoint in rosacea clinical trials, their reliability has not been evaluated. OBJECTIVE: The objective of this study was to evaluate the inter- and intrarater reliability of the Clinician's Erythema Assessment (CEA), a 5-point grading scale of facial erythema severity. METHODS: Twelve board-certified dermatologists, previously trained on use of the scale, rated erythema of 28 rosacea subjects twice on the same day. Interrater and intrarater agreement was assessed with the intraclass correlation and κ statistic. RESULTS: The CEA had high interrater reliability and good intrarater reliability with an overall intraclass correlation coefficient (ICC) for session 1 and session 2 of 0.601 and 0.576, respectively; the overall weighted κ statistic for session 1 and session 2 was 0.692. LIMITATIONS: Raters were experienced dermatologists and there may be a risk of recall bias. CONCLUSION: When used by trained raters, CEA is a reliable scale for measuring the facial erythema of rosacea.
BACKGROUND:Facial erythema is a clinical hallmark of rosacea and often causes social and psychological distress. Although facial erythema assessments are a common endpoint in rosacea clinical trials, their reliability has not been evaluated. OBJECTIVE: The objective of this study was to evaluate the inter- and intrarater reliability of the Clinician's Erythema Assessment (CEA), a 5-point grading scale of facial erythema severity. METHODS: Twelve board-certified dermatologists, previously trained on use of the scale, rated erythema of 28 rosacea subjects twice on the same day. Interrater and intrarater agreement was assessed with the intraclass correlation and κ statistic. RESULTS: The CEA had high interrater reliability and good intrarater reliability with an overall intraclass correlation coefficient (ICC) for session 1 and session 2 of 0.601 and 0.576, respectively; the overall weighted κ statistic for session 1 and session 2 was 0.692. LIMITATIONS: Raters were experienced dermatologists and there may be a risk of recall bias. CONCLUSION: When used by trained raters, CEA is a reliable scale for measuring the facial erythema of rosacea.
Authors: Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland Journal: Cochrane Database Syst Rev Date: 2015-04-28
Authors: Wesley Y Yu; Brian Lu; Daniel Tan; Christine Aroyan; Kanade Shinkai; Kieron S Leslie; Lindy P Fox; Siegrid Yu; Isaac M Neuhaus; Roy C Grekin; Sarah T Arron Journal: JAMA Dermatol Date: 2020-02-01 Impact factor: 10.282
Authors: Giovanni Damiani; Laura C Gironi; Ayman Grada; Khalaf Kridin; Renata Finelli; Alessandra Buja; Nicola L Bragazzi; Paolo D M Pigatto; Paola Savoia Journal: Dermatol Ther Date: 2021-02-19 Impact factor: 3.858
Authors: Sanjana Iyengar; Paula R Williamson; Jochen Schmitt; Lena Johannsen; Ian A Maher; Joseph F Sobanko; Todd V Cartee; Daniel Schlessinger; Emily Poon; Murad Alam Journal: Trials Date: 2016-09-01 Impact factor: 2.279
Authors: John Frew; Lauren Penzi; Mayte Suarez-Farinas; Sandra Garcet; Patrick M Brunner; Tali Czarnowicki; Jaehwan Kim; Claire Bottomley; Robert Finney; Inna Cueto; Judilyn Fuentes-Duculan; Hanako Ohmatsu; Tim Lentini; Valerie Yanofsky; James G Krueger; Emma Guttman-Yassky; Daniel Gareau Journal: Exp Dermatol Date: 2020-11-30 Impact factor: 3.960